Events in Ukraine appear to be improving, but it may only be a matter of time before they take another turn for the worse. Are you prepared?» Read More
DUBLIN, March 10- U.S. fruit firm Chiquita Brands and Irish rival Fyffes, Europe's largest distributor, have struck an all-stock merger deal to create the world's biggest banana supplier. The global banana market is controlled by four multinationals, according to the United Nations: Chiquita, Fresh Del Monte, Hawaii-founded Dole Food Company and Fyffes.
DUBLIN, March 10- U.S. fruit distributor Chiquita Brands International Inc is to buy Irish rival Fyffes Plc in an all-stock deal valued at $526 million to create the world's biggest banana supplier.
Perrigo CEO Joseph Papa provides insight on the current flu season, and how it plans on getting its name better known.
Jim Cramer has been a fan of this company for quite some time. But a good stock always needs new catalysts.
Investing is a bit like an Ellery Queen mystery. If you can follow the clues you should find what you're seeking - upside.
NEW YORK, Oct 23- Aptalis Pharma Inc, a specialty drugmaker owned by private equity firm TPG Capital LP, has appointed underwriters for an initial public offering after efforts to sell the company failed, people familiar with the matter said on Wednesday.
*Sees 2013 revenue near midpoint of $19.5- $20.5 bln estimate. JERUSALEM, Oct 10- Teva Pharmaceutical Industries will cut about 5,000 jobs, 10 percent of its workforce, accelerating a cost-cutting plan as it prepares for lower-priced competition for its best-selling drug.
More large American corporations are reducing their tax bill by buying a foreign company and effectively renouncing their United States citizenship.
The Mad Money host always suggests watching for dips. But is the weakness in Perrigo really a buying opportunity?
Uncertainty about the Fed is making stocks nervous and is adding to a growing bearishness about the market.
A new development suggests big companies may be getting fed up with Washington. Really fed up.
Sick of high U.S. corporate taxes? Here's how some companies are slashing their tax bill by 10%, 20%—or more.
Who’s best for the markets, Yellen or Summers? Wall Street debates while awaiting Obama’s pick for the next Fed chairman.
Cramer says a trio of recent deals demands attention.
Stocks kicked off the week on a weak note as investors hesitated to jump in ahead of the Federal Reserve meeting and a slew of key economic reports.
This is a big week for macro news: a Federal Reserve meeting, an advance look at second-quarter U.S. growth, and July's nonfarm payroll report. But the bigger story may be the weakness of the U.S. dollar.
U.S. stock index futures ticked lower on Monday, ahead of the Federal Reserve meeting and another heavy week for second quarter earnings.
The Federal Reserve's taper talk may have rattled the financial markets but it has had one notable beneficiary: Mergers and acquisitions.
U.S. generic drugmaker Perrigo agreed to buy fellow drug company Elan for $8.6 billion on Monday in a deal that will hand it royalty rights from a blockbuster treatment and tax savings from being domiciled in Ireland.
Perrigo CEO Joe Papa discusses the biotech industry, the state of the consumer and why Mucinex is going to be a big winner for his company.